Related Articles
TERT promoter mutations and their correlation with BRAF and RAS mutations in a consecutive cohort of 145 thyroid cancer cases
NRAS and BRAF mutation frequency in primary oral mucosal melanoma
Molecular alterations in clinical stageĀ III cutaneous melanoma: Correlation with clinicopathological features and patient outcome
Clinicopathological characteristics and prognostic impact of colorectal cancers with NRAS mutations
Signaling pathways in follicular cell-derived thyroid carcinomas (Review)